학술논문

Combination of atezolizumab and pirfenidone in second-line and beyond NSCLC: A phase I/II study.
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2021, 39 15, 3p. Supplement: S
Subject
Language
English
ISSN
15277755